Futura Medical PLC (AIM:FUM, OTC:FAMDF), the AIM-listed firm behind Eroxon, has appointed Panmure Liberum as its sole broker with immediate effect. The firm, which focuses on sexual health products, confirmed Panmure Liberum will also continue as its Nominated Adviser.
The Markets by Proactive
Go to Proactive UK
Proactive’s coverage of London’s small caps continues on .com